Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen G Ward

Showing results (21-30 of 64) with videos related to

Pageof 7
Sort By:
Trends in Biochemical Sciences|October 9, 2007
The PI3K inhibitor arsenal: choose your weapon!Tom Crabbe, Melanie J Welham, Stephen G Ward
Molecular Immunology|July 15, 2010
Evidence for PI3K-dependent CXCR3 agonist-induced degranulation of human cord blood-derived mast cellsIan Willox, Irina Mirkina, John Westwick, et al.
Trends in Immunology|March 6, 2007
Signalling to suit function: tailoring phosphoinositide 3-kinase during T-cell activationRichard V Parry, James L Riley, Stephen G Ward
Biochimica Et Biophysica Acta|September 29, 2009
Fine tuning T lymphocytes: a role for the lipid phosphatase SHIP-1Richard V Parry, Stephanie J Harris, Stephen G Ward
Nature Immunology|March 28, 2003
Toll-like receptors in the spotlightLuke A J O'Neill, Zarin Brown, Stephen G Ward
Current Opinion in Investigational Drugs (London, England : 2000)|October 31, 2009
PI3K isoforms as drug targets in inflammatory diseases: lessons from pharmacological and genetic strategiesStephanie J Harris, John G Foster, Stephen G Ward
Frontiers in Immunology|March 6, 2023
Editorial: Stromal and immune cell interactions in intestinal inflammation and fibrosisVassilis Valatas, Kazuya Kitamura, Stephen G Ward, et al.
Immunology|March 2, 2002
Chemokine signalling: pivoting around multiple phosphoinositide 3-kinasesAdam P Curnock, Marisa K Logan, Stephen G Ward
Drug Discovery Today|September 26, 2006
Leukocyte navigation mechanisms as targets in airway diseasesDavid A Medina-Tato, Malcolm L Watson, Stephen G Ward
Immunology|July 7, 2007
Phosphoinositide 3-kinase signalling in lung disease: leucocytes and beyondDavid A Medina-Tato, Stephen G Ward, Malcolm L Watson
Pageof 7

Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Trends in Biochemical Sciences|October 9, 2007
The PI3K inhibitor arsenal: choose your weapon!Tom Crabbe, Melanie J Welham, Stephen G Ward
Molecular Immunology|July 15, 2010
Evidence for PI3K-dependent CXCR3 agonist-induced degranulation of human cord blood-derived mast cellsIan Willox, Irina Mirkina, John Westwick, et al.
Trends in Immunology|March 6, 2007
Signalling to suit function: tailoring phosphoinositide 3-kinase during T-cell activationRichard V Parry, James L Riley, Stephen G Ward
Biochimica Et Biophysica Acta|September 29, 2009
Fine tuning T lymphocytes: a role for the lipid phosphatase SHIP-1Richard V Parry, Stephanie J Harris, Stephen G Ward
Nature Immunology|March 28, 2003
Toll-like receptors in the spotlightLuke A J O'Neill, Zarin Brown, Stephen G Ward
Current Opinion in Investigational Drugs (London, England : 2000)|October 31, 2009
PI3K isoforms as drug targets in inflammatory diseases: lessons from pharmacological and genetic strategiesStephanie J Harris, John G Foster, Stephen G Ward
Frontiers in Immunology|March 6, 2023
Editorial: Stromal and immune cell interactions in intestinal inflammation and fibrosisVassilis Valatas, Kazuya Kitamura, Stephen G Ward, et al.
Immunology|March 2, 2002
Chemokine signalling: pivoting around multiple phosphoinositide 3-kinasesAdam P Curnock, Marisa K Logan, Stephen G Ward
Drug Discovery Today|September 26, 2006
Leukocyte navigation mechanisms as targets in airway diseasesDavid A Medina-Tato, Malcolm L Watson, Stephen G Ward
Immunology|July 7, 2007
Phosphoinositide 3-kinase signalling in lung disease: leucocytes and beyondDavid A Medina-Tato, Stephen G Ward, Malcolm L Watson
Pageof 7